PLEGINE Drug Patent Profile
✉ Email this page to a colleague
When do Plegine patents expire, and when can generic versions of Plegine launch?
Plegine is a drug marketed by Wyeth Ayerst and is included in one NDA.
The generic ingredient in PLEGINE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Plegine
A generic version of PLEGINE was approved as phendimetrazine tartrate by VIRTUS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PLEGINE?
- What are the global sales for PLEGINE?
- What is Average Wholesale Price for PLEGINE?
Summary for PLEGINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 21 |
| Patent Applications: | 1,902 |
| DailyMed Link: | PLEGINE at DailyMed |
US Patents and Regulatory Information for PLEGINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | PLEGINE | phendimetrazine tartrate | TABLET;ORAL | 012248-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
